Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Global Central Lab Market Outlook (2023 to 2033)

The global central lab market size, in terms of value, is estimated to be around US$ 2,543.9 million in 2023. During the market forecast period from 2023 to 2033, the overall market is anticipated to expand at a CAGR of 5.8%. By the end of 2033, the net worth of total business by central labs worldwide could reach up to US$ 4,473.5 million.

Central Lab Market Trends

  • Increase in clinical trials and an increase in the prevalence of genetic illnesses.
  • New medications and medical gadgets are constantly being developed through clinical trials at such modern facilities.
  • Central labs guarantee that findings are supplied more quickly and accurately.
  • Providing drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.
  • There is a pressing need to lower the expense of pharmaceutical research and development processes.
Report Attribute Details
Central Lab Market Share (2023) US$ 2,543.9 million
Market Anticipated Forecast Value (2033) US$ 4,473.5 million
Market Projected Growth Rate (2023 to 2033) 5.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Analysis of Historical Period from 2018 to 2022 Compared to Forecast Outlook for 2023 to 2033

According to our market survey, the demand for central lab services surged at 4.1% CAGR from 2018 to 2022 with a market valuation of US$ 2,422.7 million. During the evaluation period, the worldwide central lab market was projected to have strong growth potential due to rising pharmaceutical and biotechnology company activities.

Attributes Details
Central Lab Market Size (2018) US$ 1,980.8 million
Market Size (2022) US$ 2,422.7 million
Market (CAGR 2018 to 2022) 4.1%

The importance of central labs surged during the pandemic years as they witnessed tremendous opportunities regarding research and development for curbing COVID-19 spread. Also, central labs were much preferred for genetic sequencing since they have better and more advanced technology, ultimately setting the trend for the future.

Driving Factors for the Global Healthcare Central Lab Market

The need for central laboratories has increased since pharmaceutical companies always look for methods to lower the cost of medication research and manufacturing. So, giant pharmaceutical businesses are also making significant investments to establish facilities for providing central lab equipment and services in recent years.

To combat the rising burden of many chronic illnesses, several government health institutions have also come forward to encourage entrepreneurs to set up central labs. Throughout the projected period, government support is anticipated to serve as a driving force for clinical central laboratory market expansion.

In light of strict criteria for the standard of lab data in trials, central labs have recently emerged as the best choices for clinical trials. Also, the existence of advanced technologies and the inability of local laboratories to organize necessary tests has surged the demand for central labs in recent years.

Automation of procedures has boosted the central lab output as it requires less human interaction and performs better all around. Additionally, they have increased the scope of their services by integrating technological and software advancements.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges for Growth in the Central Lab Market

Clinical trials in any centralized laboratory services industry are one of the most expensive procedures that limit market expansion to certain degrees. Additionally, the necessity for significant capital expenditures to set up and run central lab equipment and services is restricting market expansion.

As central laboratory testing services deal with the healthcare sector, sufficient medical infrastructure remains a crucial challenge for the overall market. Also, regulatory difficulties have hindered the development of clinical central laboratory industry trends.

Comparative View of Adjacent Central Lab Market

The increase in clinical samples analyzed daily in recent years and other businesses assisting in the activities of central labs has also increased in parallel, according to market research. Therefore, to get a clear picture, the report compares the emerging trends in the lab automation market and laboratory information system market.

Central Lab Market:

Attributes Central Lab Market
CAGR (2023 to 2033) 5.8%
Market Value (2023) US$ 2,543.9 million
Growth Factor High complexity of clinical trials following the increasing prevalence of new types of diseases around the world.
Future Opportunities The growing demand for novel medications and vaccines with the emergence of disease-causing rare pathogens.
Market Trends The global market players are expanding central lab services in the low-income group countries.

Lab Automation Market:

Attributes Lab Automation Market
CAGR (2023 to 2033) 10.1%
Market Value (2023) US$ 2,100 million
Growth Factor Increasing focus on reducing human intervention in delicate clinical trial laboratories and facilities operations.
Future Opportunities The rising adoption and popularity of robotics equipment are significant factors in the growth of the lab automation market.
Market Trends Demand for automated products, services, and cutting-edge software has increased by three times in the last decade.

Laboratory Information System Market:

Attributes Laboratory Information System Market
CAGR (2023 to 2033) 10.2%
Market Value (2023) US$ 2,093.8 million
Growth Factor The introduction of digital technologies and lab automation software has resulted in the growth of laboratory information systems.
Future Opportunities The growing pool of patients worldwide undergoing various tests and demanding early diagnosis and storage of their health data.
Market Trends Leading software developers are working towards simplification of information that now easily reaches patients and healthcare providers.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Research and Development Activities Drive the United States Market

Owing to numerous clinical testing central labs, the United States has dominated the global market for a very long time. In 2022, the total revenue generated by the market players present in the country was around US$ 1,010.2 million. The United States market is expected to expand at a healthy rate during the forecast period with rising drug research and development activities.

Germany Acquires One-fourth of the Europe Central Lab Market

In 2022, Germany contributed roughly US$ 112 million in the total revenue of US$ 456 million generated by central lab services in Europe. An increase in genetic disorders and clinical testing services cases is poised to keep the German market profitable in the coming days. Also, some advanced central labs, including Eurofins in Luxembourg, are expected to keep the central laboratory testing services trends intact.

In the table below, we provide an estimated market share of the performing three countries in different geographical locations. The United States remains the leading market for central laboratory testing services trends. Meanwhile, Germany and Japan lead Europe and Asia markets, respectively, in demand for clinical trials.

Regional Market Comparison Global Market Share in Percentage (2023)
United States 51%
Germany 6%
Japan 3%

Growing Opportunities in Alzheimer’s Therapeutics to Drive the United Kingdom

The market in the United Kingdom could progress at a higher rate than in Germany. The growing popularity of Alzheimer’s therapeutics services in the country has substantially improved the central lab outsourcing market in recent years. In addition, strengthening the medical tourism sector is projected to drive the market at a higher rate during the forecast years.

China to Lead the Asian Courtiers in Central Lab Industrial Growth

China is the leading market for central laboratory testing services in Asia, poised to grow 7.6% through 2033. China is also likely to witness a higher growth rate in demand for lab accessories used in central labs in the next ten years. Also, favorable support from the Chinese government for improving the country's central laboratory services market outlook is expected to drive this trend.

Higher Public Investments to Bring in New Opportunities for Indian Market Players

The need for central labs has significantly increased in India with rising government and pharmaceutical company investments in the development of innovative drugs. However, regulatory difficulties and the scarcity of central labs in many emerging and impoverished locations in India are still leading concerns for market growth.

The table below represents the projected growth rates for the expansion of regional markets as per central lab market statistics and forecast. Though Asian countries like China and India are likely to witness higher growth rates, the United Kingdom and Australia are anticipated to experience remarkable growth through 2033.

Regional Markets CAGR (2023 to 2033)
United Kingdom 5.1%
China 7.6%
India 6%
Australia 4.9%

Category-wise Insights

Production of Biomarkers Creates Opportunities for Central Lab Service Providers

The incidence of chronic illnesses, including cancer, Alzheimer's disease, and diabetes, is on the rise and could drive the business of the central labs. This trend demonstrates the rising demand for biomarkers that form the leading service segment and generated almost US$ 772.5 million in 2022.

Attributes Details
Top Service Type Biomarker
Market Share in 2023 39%

Based on End Use, Pharmaceutical Sector to Overtake Biotechnology Segment Soon

Central labs are primarily located where most clinical studies are carried out, limiting the business opportunities for the central diagnostic laboratories market. So, new drug discovery is the primary activity in central labs, resulting in the biotechnology sector being the dominant end-user segment for the overall market. However, the rising need for novel medications and vaccines after the pandemic has strengthened the market position of the pharmaceutical segment.

Attributes Details
Top End User Biotechnology
Market Share in 2023 42%

Central Lab Market Competitive Landscape

Multinational corporations are noticeably at the forefront of the adoption of services provided by central labs because of the many advantages they provide. Furthermore, to enhance the services provided by the central lab business, global market players are adopting collaborations and agreements as essential development tactics.

Emmes is a renowned organization that provides full-service clinical research with a focus on rare diseases. Likewise, the ICON plc acquired MolecularMD laboratory in February 2019. It is a molecular diagnostic specialty laboratory that facilitates discovering, developing, and commercializing discovered medicines for cancer treatment. It aims to expand ICON's testing platforms, including next-generation sequencing and immunohistochemistry, by improving the laboratory's ability in molecular diagnostic testing.

Regional expansion to Asian countries is a strategy for global businesses to expand after the saturation of current distribution channels. Many central lab service providers in the United States are employing this strategy to draw in additional clients from adjacent countries and Latin America.

The Alba Campus in Livingston, Scotland, expanded its laboratory and operational capabilities starting in June 2021, according to a statement from Q2 Solutions. Alba Camus is a premier global provider of clinical trial services for pharmaceutical laboratories and supports new growth areas for biopharma and pharma clients globally. Besides being a wholly owned subsidiary of IQVIA, it is expanding its capabilities for genomics, flow cytometry, and translational science laboratory services.

Recent Development

  • The CRO announced in September 2021 that it has extended its partnership with Eurofins Central Laboratory by signing a five-year service agreement.
  • In 2023, Ampath expanded its reference lab in India, Gurgaon. The lab offers diagnostic tests in hematology, clinical pathology, serology, immunology, and microbiology.
  • In 2023, Karkinos Healthcare collaborated with Bayer, a pharmaceutical company in India, to strengthen its oral, breast, cervix, colorectal, and prostate cancer screening.

Key Players Profiled in the Central Lab Market Report

  • Covance (Labcorp)
  • Eurofins Global Central Library
  • PPD Central Lab
  • ICON Central Labs
  • Medpace Reference Laboratory
  • Q² Solutions
  • ACM Global Laboratories
  • Labconnect Inc.
  • Cerba Research
  • Medicover Integrated Clinical Services
  • Versiti Inc.
  • A.P. Moller Holding A/S
  • Ampersand Capital Partners
  • Lambda Therapeutics Research Ltd
  • Cirion Biopharma Research Inc.

Central Lab Market Report Scope

Report Attributes Details
Growth Rate CAGR of 5.8% from 2023 to 2033
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million or billion, Volume in Kilotons, and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • By Service Type
  • By End Use
  • By Region
Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • The Middle East and Africa (MEA)
Key Countries Profiled
  • United States
  • Canada
  • Brazil
  • Argentina
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASIAN
  • GCC Countries
  • South Africa
Key Companies Profiled
  • Covance (Labcorp)
  • Eurofins Global Central Library
  • PPD Central Lab
  • ICON Central Labs
  • Medpace Reference Laboratory
  • Q² Solutions
  • ACM Global Laboratories
  • Labconnect Inc.
  • Cerba Research
  • Medicover Integrated Clinical Services
  • Versiti Inc.
  • A.P. Møller Holding A/S
  • Ampersand Capital Partners
  • Lambda Therapeutics Research Ltd
  • Cirion Biopharma Research Inc.
Customization & Pricing Available Upon Request

Key Segments Profiled in the Central Lab Industry Survey

By Service Type:

  • Genetic Services
  • Biomarker Services
  • Microbiology Services
  • Special Chemistry Services
  • Other Service Types

By End User:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • The Middle East & Africa (MEA)

Frequently Asked Questions

How Big is the Central Laboratory Market Worldwide?

The global central laboratory market value in 2023 is roughly US$ 2,543.9 million.

What is the Growth Outlook of the Central Lab Market?

The global market is likely to record a 5.8% CAGR through 2033.

What is the Market Forecast for Central Laboratory Services by 2033?

The global central lab market value could reach US$ 4,473.5 million by 2033.

Which Country Rules the Global Central Lab Market?

The United States alone accounts for over 50% of the global market.

Which Country is Likely to Experience Lucrative Growth in the Central Lab Market?

China is predicted to witness a CAGR of 7.6% through 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Service Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Service Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service Type, 2023 to 2033

        5.3.1. Genetic Services

        5.3.2. Biomarker Services

        5.3.3. Microbiology Services

        5.3.4. Anatomic Pathology/Histology

        5.3.5. Specimen Management & Storage

        5.3.6. Special Chemistry Services

        5.3.7. Others

    5.4. Y-o-Y Growth Trend Analysis By Service Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Service Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Pharmaceutical Companies

        6.3.2. Biotechnology Companies

        6.3.3. Academic and Research Institutes

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Service Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Service Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Service Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Service Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. UK

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Service Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Service Type

        10.3.3. By End User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Service Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Service Type

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Service Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Service Type

        12.3.3. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Service Type

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Service Type

        13.3.3. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Service Type

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Service Type

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Service Type

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Service Type

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Service Type

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Service Type

            15.4.2.2. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Service Type

            15.5.2.2. By End User

    15.6. UK

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Service Type

            15.6.2.2. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Service Type

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Service Type

            15.8.2.2. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Service Type

            15.9.2.2. By End User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Service Type

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Service Type

            15.11.2.2. By End User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Service Type

            15.12.2.2. By End User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Service Type

            15.13.2.2. By End User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Service Type

            15.14.2.2. By End User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Service Type

            15.15.2.2. By End User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Service Type

            15.16.2.2. By End User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Service Type

            15.17.2.2. By End User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Service Type

            15.18.2.2. By End User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Service Type

            15.19.2.2. By End User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Service Type

            15.20.2.2. By End User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Service Type

            15.21.2.2. By End User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Service Type

            15.22.2.2. By End User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Service Type

            15.23.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Service Type

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Covance(Labcorp)

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Eurofins Global Central Library

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. PPD Central Lab

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. ICON Central Labs

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Medpace Reference Laboratory

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Q² Solutions

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Barc Lab

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Frontage Labs

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. ACM Global Laboratories

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Celerion

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Laboratory Information System Market

Published : January 2024

Healthcare

Lab Automation Market

Published : January 2023

Healthcare

Lab Chip Devices Market

Published : December 2022

Healthcare

Lab Accessories Market

Published : June 2022

Explore Healthcare Insights

View Reports